{
  "ticker": "XERS",
  "company_name": "Xeris Biopharma Holdings, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04074317",
      "title": "Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 1, Insulin-dependent Diabetes Mellitus",
      "start_date": "2019-08-22",
      "completion_date": "2020-04-02",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT02411578",
      "title": "Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 1",
      "start_date": "2015-09",
      "completion_date": "2016-05",
      "enrollment": 0,
      "sponsor": "Jaeb Center for Health Research"
    },
    {
      "nct_id": "NCT03255629",
      "title": "Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Post-bariatric Hypoglycemia",
      "start_date": "2017-09-19",
      "completion_date": "2018-08-22",
      "enrollment": 0,
      "sponsor": "Joslin Diabetes Center"
    },
    {
      "nct_id": "NCT02937558",
      "title": "CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Congenital Hyperinsulinism",
      "start_date": "2016-10",
      "completion_date": "2018-10",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT03738865",
      "title": "G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Insulin Hypoglycemia, Type 1 Diabetes Mellitus, Severe Hypoglycemia",
      "start_date": "2018-09-27",
      "completion_date": "2019-04-02",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT02660242",
      "title": "The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 1",
      "start_date": "2016-01",
      "completion_date": "2017-02-15",
      "enrollment": 0,
      "sponsor": "Jaeb Center for Health Research"
    },
    {
      "nct_id": "NCT02423980",
      "title": "G-Pen\u2122 for Hypoglycemia Rescue in T1D Patients",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypoglycemia",
      "start_date": "2015-04",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT02656069",
      "title": "Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypoglycemia, Diabetes Mellitus, Type 1",
      "start_date": "2017-03-15",
      "completion_date": "2017-09-25",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT01972152",
      "title": "Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypoglycemia",
      "start_date": "2013-10",
      "completion_date": "2014-02",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    },
    {
      "nct_id": "NCT03091673",
      "title": "Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Diabetes Mellitus, Type 1",
      "start_date": "2017-03-27",
      "completion_date": "2017-09-27",
      "enrollment": 0,
      "sponsor": "Xeris Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 19,
    "by_phase": {
      "PHASE2": 13,
      "PHASE1, PHASE2": 1,
      "PHASE3": 4,
      "PHASE1": 1
    },
    "by_status": {
      "COMPLETED": 18,
      "TERMINATED": 1
    },
    "active_trials": 0,
    "completed_trials": 18,
    "conditions": [
      "Congenital Hyperinsulinism",
      "Diabetes Mellitus, Type 1",
      "Diabetes Mellitus, Type 1, Insulin-dependent Diabetes Mellitus",
      "Hyperinsulinemic Hypoglycemia",
      "Hypoglycemia",
      "Hypoglycemia Unawareness, Diabetes Mellitus, Type 1",
      "Hypoglycemia, Complications of Bariatric Procedures",
      "Hypoglycemia, Diabetes Mellitus, Type 1",
      "Hypothyroidism",
      "Insulin Hypoglycemia, Type 1 Diabetes Mellitus, Severe Hypoglycemia",
      "Post-bariatric Hypoglycemia",
      "Type1diabetes"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:23:00.058805",
    "search_query": "Xeris Biopharma Holdings, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Xeris+Biopharma+Holdings,+Inc."
  }
}